Shelley Force Aldred

SwitchGear Genomics, Inc. provides products for studying regulatory elements in the human genome. It launches LightSwitch Synthetic Response Element which is used for understanding transcription factor activity in living cells. The firms endogenous human promoter vectors are used in primary screening assays to understand how drug candidates may affect biological pathways. The company was founded by Richard M. Myers, Nathan D. Trinklein and Shelley Force Aldred in 2006 and is headquartered in Menlo Park, CA.

Seismic Bio, Inc. is an American preclinical stage biopharmaceutical company that specializes in developing bispecific therapeutic antibodies to activate the immune system to fight cancer. The private company focuses on treating solid tumor types that do not respond to immune checkpoint inhibitors. Seismic Bio uses cutting-edge science at the intersection of genomics and immunology to create therapeutic bispecific antibodies that provide tuned and targeted stimulation to the immune system, ensuring broad therapeutic windows. The company was founded by Shelley Force Aldred, who has been the CEO since incorporation.

Rondo Therapeutics, Inc. develops bispecific therapeutic antibodies to fight cancer. The American company was founded by Nathan D. Trinklein, Shelley Force Aldred. Shelley Force Aldred has been the CEO since incorporation.